CMEology

CMEology

Overview

With over 25 years in developing continuing education activities, we know how to engage health care providers. At CMEology, our ideas begin and end with the patient. Our activities embrace the National Quality Strategy and are designed to improve the effectiveness of patient care. We strive to provide meaningful learning experiences that inspire and empower. Our outcomes include quantitative assessments with descriptive statistics and subgroup analyses, qualitative results, and outcomes impact analysis and modeling.


Fact or Fiction? Test Your Knowledge on Assessment and Management Strategies in Tardive Dyskinesia

At any given time, roughly one-quarter of individuals taking antipsychotics experience TD, a condition characterized by involuntary movements of the face and body. Moreover, as the use of antipsychotics has expanded to disorders such as depression, behavioral disorders, and dementia, TD is no longer primarily limited to patients with schizophrenia. TD has an outsized impact on patients’ abilit...
CMEology

One Size Does Not Fit All: Optimizing Use of Major Depressive Disorder Specifiers to Improve Outcomes

Major depressive disorder (MDD) is a highly heterogeneous disorder that is increasingly seen as a continuum, with emphasis on overlapping and subthreshold symptoms. To address this issue, the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) included the use of specifiers, such as mixed features and anxious distress, with the diagnosis of MDD. Although DSM-5 spec...
CMEology

Strategies for Neuroprotection, Relapse Prevention, and Mortality Reduction in Patients with Schizophrenia

Only a minority of patients with schizophrenia consistently adhere to their oral antipsychotics. Long-acting injectable (LAI) formulations of antipsychotics improve patient outcomes through both neuroprotection and improved adherence. To ensure that more patients with schizophrenia are offered the opportunity to take LAIs, clinicians who provide psychiatric care must possess accurate information...
CMEology

The Debate on Eight: Controversies in Contemporary Care for Patients with Hemophilia A - Module 1: The Current Role of Plasma-Derived Therapies for Hemophilia A

This activity focuses on the current role of plasma-derived therapies for hemophilia. Topics include the importance of FVIII and hemostasis, bone, cardiovascular, and neurologic considerations, prophylaxis and pharmacokinetics, and safety of plasma-derived products including viral transmission versus recombinant inhibitor development. Two faculty take part in a conversation with audio and synchr...
CMEology

The Debate on Eight: Controversies in Contemporary Care for Patients with Hemophilia A - Module 2: The Evolving and Future Role of Plasma-Derived Therapies

This activity encompasses the evolving and future role of plasma-derived therapies including the importance of ADAMTS13 for congenital thrombotic thrombocytopenic purpura, optimal use of plasma-derived FVIII products, and immune tolerance induction in patients with inhibitors. Two faculty take part in a conversation with audio and synchronized slides. For each topic, the faculty members present ...
CMEology

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.